Create Alert
Watchlist

Abbott India

23590.10
-89.40 (0.38%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
23,920.00
Prev. Close
23,679.50
Volume
4,161
Total traded value
9.82 Cr
Upper Circuit
26,047.45
Lower Circuit
21,311.55

Market Depth

Buy order quantity
Sell order quantity
%
%
Loading...
Bid Total
2,938
Loading...
Ask Total
3,305

Analyst Estimates

83%
Buy
83%
Hold
0%
Sell
17%
Aggregated by Refinitiv from 6 Analysts

Fundamentals

Market Cap₹50,311Cr
ROE34.78%
P/E Ratio(TTM)46.52
EPS(TTM)508.91
P/B Ratio16.18
Dividend Yield1.37%
Industry P/E41.50
Book Value1463.02
Debt to Equity0.03
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Abbott India

Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.;
Parent OrganisationAbbott India Limited
Founded1944
Managing DirectorMr. Vivek Kamath
NSE SymbolABBOTINDIA

Shareholding Pattern

Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Promoters
74.99%
Retail And Others
16.11%
Mutual Funds
7.32%
Other Domestic Institutions
1.39%
Foreign Institutions
0.19%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
₹1,227.05
(-0.34%)
34.56
Cipla
₹1,211.85
(+0.51%)
28.21
Dr Reddy's Laboratories
₹5,755.30
(+0.10%)
18.83
Mankind Pharma
NA
(0.00%)
49.31
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW